Results don't
arrive in week one.
The most common misunderstanding about MSC therapy is what change should look like at two weeks, four weeks, and four months. A plain reading of how the response actually unfolds.
Normal to feel nothing yet. Paracrine signaling is slow, not pharmacologic.
Where meaningful change typically emerges. Not dramatic, steady.
Where best-achieved outcomes usually land for qualifying candidates.
MSCs are slow ,
and that's expected.
Mesenchymal stem cells don't act like a drug. They modulate the joint environment through signaling molecules over weeks to months. Meaningful response cannot happen in week one.
The mechanism is paracrine: the cells release bioactive molecules that modify inflammation, support resident tissue biology, and influence the local environment. That process unfolds over time.
A slower response curve also means a more durable one. When change arrives at three to six months, it tends to hold rather than spike-and-fade.
No dramatic overnight relief. No "I walked out and felt new." That's not how this mechanism works. If a clinic promises rapid relief, that's a red flag worth pausing on.
The realistic
response curve.
Post-procedure soreness
Mild soreness at the injection site for 24 to 48 hours. Ice, acetaminophen as needed. No NSAIDs, they blunt the response.
The quiet phase
Baseline pain largely unchanged. Normal. Do not interpret silence as failure.
First meaningful signal
Morning stiffness reduces. Sleep improves. Activities that had been avoided start returning, quietly at first.
Measurable function
KOOS / HOOS / ASES / ODI scores improve at 90 days for most responders. This is the window where the shift becomes legible.
Peak window
Best-achieved relief for most responders. Some patients benefit from a booster at six months. Others plateau and hold.
Durability
Responders typically hold meaningful relief for one to three years. Subset go longer with ongoing loading and conditioning.
The most honest way to evaluate progress is not week-over-week but against your three-month-prior self. Gradual change is easy to miss in real-time.
We track response on standardized scales at 30, 60, and 90 days. Structured measurement, not "how do you feel today."
Signals of
response.
Response doesn't announce itself in pain relief alone. The leading indicators are subtler, and often show up before the VAS score moves.
The patients who end up with the best outcomes usually notice these shifts between weeks four and twelve. Track them rather than just tracking pain.
Morning stiffness reduces
The first sixty seconds of moving in the morning. This often shifts before pain with activity does.
Sleep improves
Reduced night-pain awakening. Patients sleeping through the night for the first time in months.
NSAID use drops
Patients reach for ibuprofen less frequently. Often unconscious, noticed when the bottle lasts longer.
Avoided activities return
The hike, the yoga class, the stairs, the bike. The clearest functional signal.
When response
doesn't show.
Not every patient responds. A subset of candidates, even well-screened ones, see limited improvement at the six-month mark. This is real and we talk about it directly.
When a six-month review shows a flat response, the next conversation is about what that means: candidacy for a booster, re-evaluation for surgical consultation, or a combination of both.
No outcome is guaranteed. Registry data shows meaningful improvement in the majority of qualifying candidates, but a minority don't respond. We structure follow-up specifically to identify that early, not to paper over it.
Timeline
questions.
Q.01I haven't felt anything at week three. Is it working?
Q.02When is the earliest I could notice change?
Q.03Does taking NSAIDs during recovery hurt the response?
Q.04What if I plateau at three months?
Keep
reading.
See if the curve
applies to you.
Timeline expectations only matter once candidacy is confirmed. The evaluation is a physician reading your imaging and telling you plainly what's reasonable to expect.